All About Multiple Sclerosis

More MS news articles for January 2003

Myelin sheaths: glycoproteins involved in their formation, maintenance and degeneration

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12530518&dopt=Abstract

Cell Mol Life Sci 2002 Nov;59(11):1851-71
Quarles RH.
Myelin and Brain Development Section, Laboratory of Molecular and Cellular Neurobiology, National Institute of Neurological Disorders and Stroke, Room 2 A28, Building 49, MSC 4440, 49 Convent Drive, NIH, Bethesda Maryland 20892, USA.

Myelin sheaths are formed around axons by extending, biochemically modifying and spiraling plasma membranes of Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS).

Because glycoproteins are prominent components of plasma membranes, it is not surprising that they have important roles in the formation, maintenance and degeneration of myelin sheaths.

The emphasis in this review is on four integral membrane glycoproteins.

Two of them, protein zero (P0) and peripheral myelin protein-22 (PMP-22), are components of compact PNS myelin.

The other two are preferentially localized in membranes of sheaths that are distinct from compact myelin.

One is the myelin-associated glycoprotein, which is localized at the inside of sheaths where it functions in glia-axon interactions in both the PNS and CNS.

The other is the myelin-oligodendrocyte glycoprotein, which is preferentially localized on the outside of CNS myelin sheaths and appears to be an important target antigen in autoimmune demyelinating diseases such as multiple sclerosis.